12829 related articles for article (PubMed ID: 114247)
1. [Correlation between differentiation and malignancy in human malignant melanocytes "in vivo" and "in vitro" (author's transl)].
Foa C
Bull Cancer; 1979; 66(3):235-58. PubMed ID: 114247
[TBL] [Abstract][Full Text] [Related]
2. Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro.
Aubert C; Rougé F; Galindo JR
J Natl Cancer Inst; 1980 May; 64(5):1029-40. PubMed ID: 6929009
[TBL] [Abstract][Full Text] [Related]
3. Ultrastruct and biochemical chantes in cultured human malignant melanoma cells after heterotransplantation into nude mice.
Aubert C; Chirieceanu E; Foa C; Rorsman H; Rosengren E; Rougé F
Cancer Res; 1976 Sep; 36(9 pt.1):3106-12. PubMed ID: 975076
[TBL] [Abstract][Full Text] [Related]
4. [Differentiation and tumorigenicity of human malignant melanocytes. Comparative study of two "non pigmented" and pigmented lines from the same fibroblastoid cells].
Aubert C; Rougé F; Galindo JR
C R Seances Acad Sci D; 1979 Mar; 288(10):919-22. PubMed ID: 111834
[TBL] [Abstract][Full Text] [Related]
5. Co-regulation of melanin precursors and tyrosinase in human pigment cells: roles of cysteine and glutathione.
Benathan M; Virador V; Furumura M; Kobayashi N; Panizzon RG; Hearing VJ
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):981-90. PubMed ID: 10644002
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
7. The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression.
Eisen T; Easty DJ; Bennett DC; Goding CR
Oncogene; 1995 Nov; 11(10):2157-64. PubMed ID: 7478537
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix modulates the function of human melanocytes but not melanoma cells.
Ranson M; Posen S; Mason RS
J Cell Physiol; 1988 Aug; 136(2):281-8. PubMed ID: 3137234
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural comparison between cultured and tumor cells of human malignant melanoma.
Foa C; Aubert C
Cancer Res; 1977 Nov; 37(11):3957-63. PubMed ID: 908035
[TBL] [Abstract][Full Text] [Related]
10. [Anatomo-pathologic and ultrastructural study in a case of melanoma in the golden Syrian hamster chemically induced by 9,10 dimethyl-1,2-benzanthracene (DMBA) and transplantable].
De Micco-Pagis C; Verrier-Ferret C; Bonneau HP; Bonneau H
Bull Cancer; 1976; 63(1):73-86. PubMed ID: 825163
[TBL] [Abstract][Full Text] [Related]
11. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
12. [A newly established melanoma cell line (GAK) with 5-S-cysteinyldopa phenotype].
Nozawa S; Ohta H; Tsukazaki K; Udagawa Y; Kurihara S; Kano S
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jun; 36(6):883-92. PubMed ID: 6431036
[TBL] [Abstract][Full Text] [Related]
13. Melanocyte culture lines from Tyr-SV40E transgenic mice: models for the molecular genetic evolution of malignant melanoma.
Larue L; Dougherty N; Bradl M; Mintz B
Oncogene; 1993 Mar; 8(3):523-31. PubMed ID: 8382353
[TBL] [Abstract][Full Text] [Related]
14. Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma.
Jimbow K; Miyake Y; Homma K; Yasuda K; Izumi Y; Tsutsumi A; Ito S
Cancer Res; 1984 Mar; 44(3):1128-34. PubMed ID: 6318981
[TBL] [Abstract][Full Text] [Related]
15. Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype.
Albino AP; Sozzi G; Nanus DM; Jhanwar SC; Houghton AN
Oncogene; 1992 Nov; 7(11):2315-21. PubMed ID: 1437153
[TBL] [Abstract][Full Text] [Related]
16. Environmental modulation of the expression of differentiation and malignancy in six human squamous cell carcinoma cell lines.
Boukamp P; Rupniak HT; Fusenig NE
Cancer Res; 1985 Nov; 45(11 Pt 2):5582-92. PubMed ID: 4053033
[TBL] [Abstract][Full Text] [Related]
17. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
Ito S; Jimbow K; Kato T; Kiyota M; Fujita K
Acta Derm Venereol; 1983; 63(6):463-7. PubMed ID: 6198833
[TBL] [Abstract][Full Text] [Related]
18. Expression of proliferating cell nuclear antigen (PCNA): proliferative phase functions and malignant transformation of melanocytes.
Iyengar B
Melanoma Res; 1994 Oct; 4(5):293-5. PubMed ID: 7858412
[TBL] [Abstract][Full Text] [Related]
19. Melanogenesis in cultured human neuroblastomas.
Aubert C; Janiaud P; Rouge F; Hansson C; Rorsman H; Rosengren E
Ann Clin Res; 1980 Dec; 12(6):288-94. PubMed ID: 6786205
[TBL] [Abstract][Full Text] [Related]
20. Malignant potential of cells isolated from lymph node or brain metastases of melanoma patients and implications for prognosis.
Zhang RD; Price JE; Schackert G; Itoh K; Fidler IJ
Cancer Res; 1991 Apr; 51(8):2029-35. PubMed ID: 1826230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
